(S (S (VP (VBG Analyzing) (NP (JJ large) (HYPH -) (NN scale)))) (, ,) (NP (JJ multi-experiment) (NNS studies)) (VP (VBZ requires) (NP (NNS scientists)) (S (VP (TO to) (VP (VP (VB test) (NP (DT each) (JJ experimental) (NN outcome)) (PP (IN for) (NP (JJ statistical) (NN significance)))) (CC and) (ADVP (RB then)) (VP (VB assess) (NP (DT the) (NNS results)) (PP (IN as) (NP (DT a) (NN whole)))))))) (. .))
(S (NP (PRP We)) (VP (VBP present) (NP (NP (NP (NNP Black) (NNP Box) (NNP FDR)) (-LRB- -LRB-) (NP (NNP BB) (HYPH -) (NNP FDR)) (-RRB- -RRB-)) (, ,) (NP (NP (DT an) (JJ empirical) (HYPH -) (JJ Bayes) (NN method)) (PP (IN for) (S (VP (VBG analyzing) (NP (NP (JJ multi-experiment) (NNS studies)) (SBAR (WHADVP (WRB when)) (S (NP (JJ many) (NNS covariates)) (VP (VBP are) (VP (VBN gathered) (PP (IN per) (NP (NN experiment)))))))))))))) (. .))
(S (NP (NN BB) (HYPH -) (NN FDR)) (VP (VBZ learns) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NML (JJ black) (NN box)) (JJ predictive) (NNS models)))) (S (VP (TO to) (VP (VP (VB boost) (NP (NN power))) (CC and) (VP (VB control) (NP (NP (DT the) (JJ false) (NN discovery) (NN rate)) (-LRB- -LRB-) (NP (NN FDR)) (-RRB- -RRB-)) (PP (IN at) (NP (NP (CD two) (NNS stages)) (PP (IN of) (NP (NN study) (NN analysis)))))))))) (. .))
(S (PP (IN In) (NP (NN Stage) (CD 1))) (, ,) (NP (PRP it)) (VP (VBZ uses) (NP (DT a) (JJ deep) (JJ neural) (NN network)) (PP (JJ prior)) (S (VP (TO to) (VP (VB report) (SBAR (WHNP (WDT which)) (S (NP (NNS experiments)) (VP (VBD yielded) (NP (JJ significant) (NNS outcomes))))))))) (. .))
(S (PP (IN In) (NP (NN Stage) (CD 2))) (, ,) (NP (NP (DT a) (JJ separate) (JJ black) (NN box) (NN model)) (PP (IN of) (NP (DT each) (NN covariate)))) (VP (VBZ is) (VP (VBN used) (S (VP (TO to) (VP (VB select) (NP (NP (NNS features)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (NP (NP (JJ significant) (JJ predictive) (NN power)) (PP (IN across) (NP (DT all) (NNS experiments))))))))))))) (. .))
(S (PP (IN In) (NP (NNS benchmarks))) (, ,) (NP (NN BB) (HYPH -) (NN FDR)) (VP (VBZ outperforms) (NP (NP (VBG competing) (NML (NML (NN state)) (HYPH -) (PP (IN of) (HYPH -) (NP (DT the) (HYPH -) (NN art)))) (NNS methods)) (PP (IN in) (NP (NP (DT both) (NNS stages)) (PP (IN of) (NP (NN analysis))))))) (. .))
(S (NP (PRP We)) (VP (VBP apply) (NP (NN BB) (HYPH -) (NN FDR)) (PP (IN to) (NP (NP (CD two) (JJ real) (NNS studies)) (PP (IN on) (NP (NML (NN cancer) (NN drug)) (NN efficacy)))))) (. .))
(S (PP (IN For) (NP (DT both) (NNS studies))) (, ,) (NP (NN BB) (HYPH -) (NN FDR)) (VP (VP (VBZ increases) (NP (NP (DT the) (NN proportion)) (PP (IN of) (NP (NP (JJ significant) (NNS outcomes)) (VP (VBN discovered)))))) (CC and) (VP (VBZ selects) (NP (NP (NNS variables)) (SBAR (WHNP (WDT that)) (S (VP (VBP reveal) (NP (NP (JJ key) (JJ genomic) (NNS drivers)) (PP (IN of) (NP (NN drug) (NN sensitivity) (CC and) (NN resistance)))) (PP (IN in) (NP (NN cancer))))))))) (. .))
